chr15-61854888-C-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_020821.3(VPS13C):c.11143G>T(p.Asp3715Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,613,262 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020821.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VPS13C | NM_020821.3 | c.11143G>T | p.Asp3715Tyr | missense_variant | 84/85 | ENST00000644861.2 | |
LOC124903501 | XR_007064668.1 | n.159+5416C>A | intron_variant, non_coding_transcript_variant | ||||
VPS13C | NM_017684.5 | c.11014G>T | p.Asp3672Tyr | missense_variant | 82/83 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VPS13C | ENST00000644861.2 | c.11143G>T | p.Asp3715Tyr | missense_variant | 84/85 | NM_020821.3 | P3 | ||
ENST00000642740.1 | n.172+5416C>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 154AN: 152160Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000959 AC: 240AN: 250382Hom.: 1 AF XY: 0.00111 AC XY: 150AN XY: 135338
GnomAD4 exome AF: 0.00147 AC: 2141AN: 1460984Hom.: 4 Cov.: 31 AF XY: 0.00144 AC XY: 1050AN XY: 726786
GnomAD4 genome AF: 0.00101 AC: 154AN: 152278Hom.: 1 Cov.: 32 AF XY: 0.000886 AC XY: 66AN XY: 74468
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | VPS13C: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 22, 2023 | BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 21, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 3715 of the VPS13C protein (p.Asp3715Tyr). This variant is present in population databases (rs62007358, gnomAD 0.2%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with VPS13C-related conditions. ClinVar contains an entry for this variant (Variation ID: 1515129). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at